Spyre Therapeutics, Inc. ($SYRE)
Filing Information
| Accession Number | 0001636282-26-000069 |
|---|---|
| Form Type | 4 |
| Filing Date | May 29, 2026 |
| Document | View SEC Filing |
Transactions
1
Total Shares
8,026
Total Value
$0.00
P&L
+inf% (+$837,513.10)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Stock Option (Right to Buy) | Derivative | May 27, 2026 | Grant/Award | 8,026 | $0.00 | $0.00 | 8,026 | Indirect | By Tomas Kiselak | View Details |